Notice of Issuance of Final Determination Concerning Certain Surgical and Isolation Gowns, 26503-26504 [2017-11839]
Download as PDF
Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for review, discussion, and evaluation of
individual intramural programs and
projects conducted by the NATIONAL
LIBRARY OF MEDICINE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, Lister Hill National Center for
Biomedical Communications.
Date: September 7–8, 2017.
Open: September 7, 2017, 9:00 a.m. to
12:00 p.m.
Agenda: Review of research and
development programs and preparation of
reports of the Lister Hill National Center for
Biomedical Communications.
Place: National Library of Medicine,
Building 38, 2nd Floor, The Lindberg Room,
8600 Rockville Pike, Bethesda, MD 20892.
Closed: September 7, 2017, 12:00 p.m. to
4:30 p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Place: National Library of Medicine,
Building 38, 2nd Floor, The Lindberg Room,
8600 Rockville Pike, Bethesda, MD 20892.
Closed: September 8, 2017, 9:00 a.m. to
10:00 a.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Place: National Library of Medicine,
Building 38, 2nd Floor, The Lindberg Room,
8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: Karen Steely, Program
Assistant, Lister Hill National Center for
Biomedical Communications, National
Library of Medicine, Building 38A, Room
7S707, Bethesda, MD 20892, 301–827–4385,
ksteely@mail.nih.gov.
Open: September 8, 2017, 10:00 a.m. to
11:30 a.m.
Agenda: Review of research and
development programs and preparation of
reports of the Lister Hill National Center for
Biomedical Communications.
Place: National Library of Medicine,
Building 38, 2nd Floor, The Lindberg Room,
8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: Karen Steely, Program
Assistant, Lister Hill National Center for
Biomedical Communications, National
Library of Medicine, Building 38A, Room
7S707, Bethesda, MD 20892, 301–827–4385,
ksteely@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
VerDate Sep<11>2014
16:37 Jun 06, 2017
Jkt 241001
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS).
Dated: June 1, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–11721 Filed 6–6–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Notice of Issuance of Final
Determination Concerning Certain
Surgical and Isolation Gowns
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
AGENCY:
This document provides
notice that U.S. Customs and Border
Protection (‘‘CBP’’) has issued a final
determination concerning the country of
origin of certain surgical and isolation
gowns. Based upon the facts presented,
CBP has concluded in the final
determination that the Dominican
Republic is the country of origin of the
surgical and isolation gowns for
purposes of U.S. Government
procurement.
SUMMARY:
The final determination was
issued on May 31, 2017. A copy of the
final determination is attached. Any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of
this final determination within July 7,
2017.
DATES:
FOR FURTHER INFORMATION CONTACT:
Cynthia Reese, Valuation and Special
Programs Branch, Regulations and
Rulings, Office of Trade (202–325–
0046).
Notice is
hereby given that on May 31, 2017,
pursuant to Subpart B of part 177,
Customs and Border Protection (CBP)
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
26503
Regulations (19 CFR part 177, subpart
B), CBP issued a final determination
concerning the country of origin of
certain surgical and isolation gowns
which may be offered to the United
States Government under an
undesignated government procurement
contract. This final determination, in
HQ H284665, was issued at the request
of Global Resources International, Inc.,
under procedures set forth at 19 CFR
part 177, subpart B, which implements
Title III of the Trade Agreements Act of
1979, as amended (19 U.S.C. 2511–18).
In the final determination, CBP has
concluded that, based upon the facts
presented, certain surgical and isolation
gowns which are produced in the
Dominican Republic from foreign
nonwoven fabric by cutting the fabric
into components and assembly of those
components in the Dominican Republic
are products of the Dominican Republic
for purposes of U.S. Government
procurement.
Section 177.29, CBP Regulations (19
CFR 177.29), provides that notice of
final determinations shall be published
in the Federal Register within 60 days
of the date the final determination is
issued. Section 177.30, CBP Regulations
(19 CFR 177.30), provides that any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of a
final determination within 30 days of
publication of such determination in the
Federal Register.
Dated: May 31, 2017.
Alice A. Kipel,
Executive Director, Regulations and Rulings,
Office of Trade.
Attachment
HQ H284665
May 31, 2017
OT:RR:CTF:VS H284665 CMR
CATEGORY: Origin
Ms. Christi Roos, LCB
M–PACT Solutions
P.O. Box 30209
Memphis, TN 38118
RE: Government Procurement; Final
Determination; Surgical and Isolation
Gowns
Dear Ms. Roos:
This ruling is in response to your request
of March 20, 2017, on behalf of your client,
Global Resources International, Inc., for a
country of origin determination for certain
surgical and isolation gowns for purposes of
government procurement under Title III of
the Trade Agreements Act of 1979 (TAA), as
amended (19 U.S.C. 2511 et seq.). Customs
and Border Protection (CBP) issues country
of origin advisory rulings and final
determinations as to whether an article is or
would be a product of a designated country
or instrumentality for the purposes of
granting waivers of certain ‘‘Buy American’’
E:\FR\FM\07JNN1.SGM
07JNN1
sradovich on DSK3GMQ082PROD with NOTICES
26504
Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices
restrictions in U.S. law or for products
offered for sale to the U.S. Government. This
final determination concerns the country of
origin of certain surgical and isolation gowns.
As an importer of this merchandise, Global
Resources International, Inc., is a party-atinterest within the meaning of 19 CFR
177.23(a) and is entitled to request this final
determination.
FACTS:
The surgical and isolation gowns at issue
were the subject of New York Ruling Letter
(NY) N283263, dated March 7, 2017, which
determined that these gowns are classified in
subheading 6210.10.50, Harmonized Tariff
Schedule of the United States (HTSUS).
Samples of each type of gown were
submitted to CBP and are described in NY
N283263 as follows:
The submitted sample, isolation gown, is
constructed from 96% spunbonded
polypropylene nonwoven fabric and 4%
cotton knit fabric. The gown has a full back
opening, long sleeves and a tie at the waist
in the front of the gown that extends around
the waist to fasten at the back. The garment
will be used in the medical industry.
The submitted sample, surgical gown, is
constructed from 100% spunbonded
polypropylene nonwoven fabric. The surgical
gown has a hook and loop closure at the
neck, long sleeves with knit cuffs and a full
back opening. There is also a tie at the waist
in the front of the gown that extends around
the waist to fasten at the back. The garment
will be used in the medical industry.
Based on information from your initial
ruling request, dated December 2, 2016, your
supplemental submission, dated January 30,
2017, NY N283263, and responses via email
to our questions, the manufacturing process
is as follows:
• Rolled nonwoven fabric from China,
Vietnam, or India is shipped to the
Dominican Republic.
• All other components including thread
and cotton fabric for the cuffs will be
manufactured in the Dominican Republic.
In the Dominican Republic:
• The nonwoven fabric is laid on a cutting
table and cut to specification using a cutting
template.
• Components are cut from the fabric—
body, left arm, right arm, ties.
• Arms are ultra-sonically welded to the
body fabric or sewn.
• In the case of the isolation gowns, the
knit cuffs are sewn to the arms.
• The gowns are folded, packaged and
shipped to the United States.
ISSUE:
What is the country of origin of the surgical
and isolation gowns described herein for
purposes of U.S. Government procurement?
LAW AND ANALYSIS:
Pursuant to Subpart B of Part 177, 19 CFR
177.21 et seq., which implements Title III,
Trade Agreements Act of 1979, as amended
(19 U.S.C. 2511–2518), CBP issues country of
origin advisory rulings and final
determinations as to whether an article is or
would be a product of a designated country
or instrumentality for the purpose of granting
waivers of certain ‘‘Buy American’’
VerDate Sep<11>2014
16:37 Jun 06, 2017
Jkt 241001
restrictions in U.S. law or practice for
products offered for sale to the U.S.
Government.
The rule of origin set forth in 19 U.S.C.
2518(4)(B) states:
An article is a product of a country or
instrumentality only if (i) it is wholly the
growth, product, or manufacture of that
country or instrumentality, or (ii) in the case
of an article which consists in whole or in
part of materials from another country or
instrumentality, it has been substantially
transformed into a new and different article
of commerce with a name, character, or use
distinct from that of the article or articles
from which it was so transformed.
See also 19 CFR 177.22(a) defining ‘‘country
of origin’’ in identical terms.
In rendering advisory rulings and final
determinations for purposes of U.S.
Government procurement, CBP applies the
provisions of Subpart B of Part 177 consistent
with the Federal Procurement Regulations.
See 19 CFR 177.21. In this regard, CBP
recognizes that the Federal Procurement
Regulations restrict the U.S. Government’s
purchase of products to U.S.-made or
designated country end products for
acquisitions subject to the TAA. See 48 CFR
25.403(c)(1).
With regard to the articles at issue, your
request involves determining whether the
articles are products of the Dominican
Republic. The Federal Acquisition
Regulations define ‘‘designated country’’ as
including a Free Trade Agreement (FTA)
country, and includes the Dominican
Republic in the list of FTA countries.
Further, the regulations define ‘‘Free Trade
Agreement country end product’’ to mean, in
relevant part, an article that:
(1) Is wholly the growth, product, or
manufacture of a Free Trade Agreement
(FTA) country; or
(2) In the case of an article that consists in
whole or in part of materials from another
country, has been substantially transformed
in an FTA country into a new and different
article of commerce with a name, character,
or use distinct from that of the article or
articles from which it was transformed. . . .
See 48 CFR 25.003.
As the articles at issue are not wholly the
growth, product, or manufacture of the
Dominican Republic, the substantial
transformation standard as set forth in 19
U.S.C. 2518(4)(B) applies. As the articles at
issue are textile products, the rules of origin
for textile products for purposes of the
customs laws and the administration of
quantitative restrictions apply.
In NY N283263, it was determined that the
surgical and isolation gowns are classified in
subheading 6210.10.50, HTSUS, and are not
wholly obtained or produced in the
Dominican Republic, their origin cannot be
determined by application of 19 CFR
102.21(c)(1), i.e., wholly obtained or
produced rule, and resort must be made to
19 CFR 102.21(c)(2), which provides that the
origin of a good is the country ‘‘in which
each foreign material incorporated in that
good underwent an applicable change in
tariff classification, and/or met any other
requirement, specified for the good in
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
paragraph (e) of [102.21].’’ Section 102.21(e)
provides, in pertinent part, for goods
classifiable in heading 6210:
(1) If the good consists of two or more
component parts, a change to an assembled
good of heading 6210 through 6212 from
unassembled components, provided that the
change is the result of the good being wholly
assembled in a single country, territory, or
insular possession.
*
*
*
*
*
The nonwoven fabric is cut in the
Dominican Republic into component parts,
i.e., the body, left arm, right arm and ties.
These components are wholly assembled in
the Dominican Republic into finished gowns.
In the case of the isolation gowns, another
component, i.e., the rib knit cuffs, are
included in the assembly process. As the
gowns are wholly assembled in the
Dominican Republic, pursuant to 19 CFR
102.21(c)(2), the country of origin of the
gowns is the Dominican Republic for U.S.
Government procurement purposes.
HOLDING:
Based on the facts and analysis set forth
above, for U.S. Government procurement
purposes, the country of origin of the surgical
and isolation gowns at issue is the
Dominican Republic.
Notice of this final determination will be
given in the Federal Register, as required by
19 CFR 177.29. Any party-at-interest other
than the party which requested this final
determination may request, pursuant to 19
CFR 177.31, that CBP reexamine the matter
anew and issue a new final determination.
Pursuant to 19 CFR 177.30, any party-atinterest may, within 30 days after publication
of the Federal Register notice referenced
above, seek judicial review of this final
determination before the Court of
International Trade.
Sincerely,
Alice A. Kipel, Executive Director
Regulations and Rulings
Office of Trade
[FR Doc. 2017–11839 Filed 6–6–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[Docket No. USCBP–2017–0016]
Request for Applicants for
Appointment to the Commercial
Customs Operations Advisory
Committee (COAC)
U.S. Customs and Border
Protection, Department of Homeland
Security (DHS).
ACTION: Committee management; request
for applicants for appointment to the
COAC.
AGENCY:
U.S. Customs and Border
Protection (CBP) is requesting that
individuals who are interested in
SUMMARY:
E:\FR\FM\07JNN1.SGM
07JNN1
Agencies
[Federal Register Volume 82, Number 108 (Wednesday, June 7, 2017)]
[Notices]
[Pages 26503-26504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11839]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
U.S. Customs and Border Protection
Notice of Issuance of Final Determination Concerning Certain
Surgical and Isolation Gowns
AGENCY: U.S. Customs and Border Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
-----------------------------------------------------------------------
SUMMARY: This document provides notice that U.S. Customs and Border
Protection (``CBP'') has issued a final determination concerning the
country of origin of certain surgical and isolation gowns. Based upon
the facts presented, CBP has concluded in the final determination that
the Dominican Republic is the country of origin of the surgical and
isolation gowns for purposes of U.S. Government procurement.
DATES: The final determination was issued on May 31, 2017. A copy of
the final determination is attached. Any party-at-interest, as defined
in 19 CFR 177.22(d), may seek judicial review of this final
determination within July 7, 2017.
FOR FURTHER INFORMATION CONTACT: Cynthia Reese, Valuation and Special
Programs Branch, Regulations and Rulings, Office of Trade (202-325-
0046).
SUPPLEMENTARY INFORMATION: Notice is hereby given that on May 31, 2017,
pursuant to Subpart B of part 177, Customs and Border Protection (CBP)
Regulations (19 CFR part 177, subpart B), CBP issued a final
determination concerning the country of origin of certain surgical and
isolation gowns which may be offered to the United States Government
under an undesignated government procurement contract. This final
determination, in HQ H284665, was issued at the request of Global
Resources International, Inc., under procedures set forth at 19 CFR
part 177, subpart B, which implements Title III of the Trade Agreements
Act of 1979, as amended (19 U.S.C. 2511-18). In the final
determination, CBP has concluded that, based upon the facts presented,
certain surgical and isolation gowns which are produced in the
Dominican Republic from foreign nonwoven fabric by cutting the fabric
into components and assembly of those components in the Dominican
Republic are products of the Dominican Republic for purposes of U.S.
Government procurement.
Section 177.29, CBP Regulations (19 CFR 177.29), provides that
notice of final determinations shall be published in the Federal
Register within 60 days of the date the final determination is issued.
Section 177.30, CBP Regulations (19 CFR 177.30), provides that any
party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial
review of a final determination within 30 days of publication of such
determination in the Federal Register.
Dated: May 31, 2017.
Alice A. Kipel,
Executive Director, Regulations and Rulings, Office of Trade.
Attachment
HQ H284665
May 31, 2017
OT:RR:CTF:VS H284665 CMR
CATEGORY: Origin
Ms. Christi Roos, LCB
M-PACT Solutions
P.O. Box 30209
Memphis, TN 38118
RE: Government Procurement; Final Determination; Surgical and
Isolation Gowns
Dear Ms. Roos:
This ruling is in response to your request of March 20, 2017, on
behalf of your client, Global Resources International, Inc., for a
country of origin determination for certain surgical and isolation
gowns for purposes of government procurement under Title III of the
Trade Agreements Act of 1979 (TAA), as amended (19 U.S.C. 2511 et
seq.). Customs and Border Protection (CBP) issues country of origin
advisory rulings and final determinations as to whether an article
is or would be a product of a designated country or instrumentality
for the purposes of granting waivers of certain ``Buy American''
[[Page 26504]]
restrictions in U.S. law or for products offered for sale to the
U.S. Government. This final determination concerns the country of
origin of certain surgical and isolation gowns. As an importer of
this merchandise, Global Resources International, Inc., is a party-
at-interest within the meaning of 19 CFR 177.23(a) and is entitled
to request this final determination.
FACTS:
The surgical and isolation gowns at issue were the subject of
New York Ruling Letter (NY) N283263, dated March 7, 2017, which
determined that these gowns are classified in subheading 6210.10.50,
Harmonized Tariff Schedule of the United States (HTSUS). Samples of
each type of gown were submitted to CBP and are described in NY
N283263 as follows:
The submitted sample, isolation gown, is constructed from 96%
spunbonded polypropylene nonwoven fabric and 4% cotton knit fabric.
The gown has a full back opening, long sleeves and a tie at the
waist in the front of the gown that extends around the waist to
fasten at the back. The garment will be used in the medical
industry.
The submitted sample, surgical gown, is constructed from 100%
spunbonded polypropylene nonwoven fabric. The surgical gown has a
hook and loop closure at the neck, long sleeves with knit cuffs and
a full back opening. There is also a tie at the waist in the front
of the gown that extends around the waist to fasten at the back. The
garment will be used in the medical industry.
Based on information from your initial ruling request, dated
December 2, 2016, your supplemental submission, dated January 30,
2017, NY N283263, and responses via email to our questions, the
manufacturing process is as follows:
Rolled nonwoven fabric from China, Vietnam, or India is
shipped to the Dominican Republic.
All other components including thread and cotton fabric
for the cuffs will be manufactured in the Dominican Republic.
In the Dominican Republic:
The nonwoven fabric is laid on a cutting table and cut
to specification using a cutting template.
Components are cut from the fabric--body, left arm,
right arm, ties.
Arms are ultra-sonically welded to the body fabric or
sewn.
In the case of the isolation gowns, the knit cuffs are
sewn to the arms.
The gowns are folded, packaged and shipped to the
United States.
ISSUE:
What is the country of origin of the surgical and isolation
gowns described herein for purposes of U.S. Government procurement?
LAW AND ANALYSIS:
Pursuant to Subpart B of Part 177, 19 CFR 177.21 et seq., which
implements Title III, Trade Agreements Act of 1979, as amended (19
U.S.C. 2511-2518), CBP issues country of origin advisory rulings and
final determinations as to whether an article is or would be a
product of a designated country or instrumentality for the purpose
of granting waivers of certain ``Buy American'' restrictions in U.S.
law or practice for products offered for sale to the U.S.
Government.
The rule of origin set forth in 19 U.S.C. 2518(4)(B) states:
An article is a product of a country or instrumentality only if
(i) it is wholly the growth, product, or manufacture of that country
or instrumentality, or (ii) in the case of an article which consists
in whole or in part of materials from another country or
instrumentality, it has been substantially transformed into a new
and different article of commerce with a name, character, or use
distinct from that of the article or articles from which it was so
transformed.
See also 19 CFR 177.22(a) defining ``country of origin'' in
identical terms.
In rendering advisory rulings and final determinations for
purposes of U.S. Government procurement, CBP applies the provisions
of Subpart B of Part 177 consistent with the Federal Procurement
Regulations. See 19 CFR 177.21. In this regard, CBP recognizes that
the Federal Procurement Regulations restrict the U.S. Government's
purchase of products to U.S.-made or designated country end products
for acquisitions subject to the TAA. See 48 CFR 25.403(c)(1).
With regard to the articles at issue, your request involves
determining whether the articles are products of the Dominican
Republic. The Federal Acquisition Regulations define ``designated
country'' as including a Free Trade Agreement (FTA) country, and
includes the Dominican Republic in the list of FTA countries.
Further, the regulations define ``Free Trade Agreement country end
product'' to mean, in relevant part, an article that:
(1) Is wholly the growth, product, or manufacture of a Free
Trade Agreement (FTA) country; or
(2) In the case of an article that consists in whole or in part
of materials from another country, has been substantially
transformed in an FTA country into a new and different article of
commerce with a name, character, or use distinct from that of the
article or articles from which it was transformed. . . .
See 48 CFR 25.003.
As the articles at issue are not wholly the growth, product, or
manufacture of the Dominican Republic, the substantial
transformation standard as set forth in 19 U.S.C. 2518(4)(B)
applies. As the articles at issue are textile products, the rules of
origin for textile products for purposes of the customs laws and the
administration of quantitative restrictions apply.
In NY N283263, it was determined that the surgical and isolation
gowns are classified in subheading 6210.10.50, HTSUS, and are not
wholly obtained or produced in the Dominican Republic, their origin
cannot be determined by application of 19 CFR 102.21(c)(1), i.e.,
wholly obtained or produced rule, and resort must be made to 19 CFR
102.21(c)(2), which provides that the origin of a good is the
country ``in which each foreign material incorporated in that good
underwent an applicable change in tariff classification, and/or met
any other requirement, specified for the good in paragraph (e) of
[102.21].'' Section 102.21(e) provides, in pertinent part, for goods
classifiable in heading 6210:
(1) If the good consists of two or more component parts, a
change to an assembled good of heading 6210 through 6212 from
unassembled components, provided that the change is the result of
the good being wholly assembled in a single country, territory, or
insular possession.
* * * * *
The nonwoven fabric is cut in the Dominican Republic into
component parts, i.e., the body, left arm, right arm and ties. These
components are wholly assembled in the Dominican Republic into
finished gowns. In the case of the isolation gowns, another
component, i.e., the rib knit cuffs, are included in the assembly
process. As the gowns are wholly assembled in the Dominican
Republic, pursuant to 19 CFR 102.21(c)(2), the country of origin of
the gowns is the Dominican Republic for U.S. Government procurement
purposes.
HOLDING:
Based on the facts and analysis set forth above, for U.S.
Government procurement purposes, the country of origin of the
surgical and isolation gowns at issue is the Dominican Republic.
Notice of this final determination will be given in the Federal
Register, as required by 19 CFR 177.29. Any party-at-interest other
than the party which requested this final determination may request,
pursuant to 19 CFR 177.31, that CBP reexamine the matter anew and
issue a new final determination. Pursuant to 19 CFR 177.30, any
party-at-interest may, within 30 days after publication of the
Federal Register notice referenced above, seek judicial review of
this final determination before the Court of International Trade.
Sincerely,
Alice A. Kipel, Executive Director
Regulations and Rulings
Office of Trade
[FR Doc. 2017-11839 Filed 6-6-17; 8:45 am]
BILLING CODE P